Floating Button
The Edge Singapore
Sign In
Home Capital Broker's Calls
Premium
Broker's Calls

Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug

Amala Balakrishner
Amala Balakrishner • 4 min read
Analysts mixed on Raffles Medical even as it appears immunised to the Covid-19 bug
The group’s PATMI of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Photo of Raffles Hospital Shanghai: Raffles Medical Group

The latest 1H2021 earnings of Raffles Medical Group shows that the healthcare provider has been immunised to the coronavirus.

The group’s PATMI (profit after taxes minus interest) of $39.4 million beat expectations of analysts from RHB and CGS-CIMB.

TAGS
Raffles Medical Group (RMG)
1H2021 results
Broker's calls
RHB Securities
DBS Group Research
CGS International

Highlights

Trending Now
Mapletree fund winds down as US$1.4 bil student dorm bet sours
Maybank initiates ‘buy’ call for Seatrium
Keppel's close of planned sale of M1 to Simba extended
Yangzijiang Financial clears the decks after China’s credit boom
Winter is coming: Singapore Inc’s moment of truth
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
Topics
Broker's CallsResultsBanking & finance
PropertyContractsAll flash categories
Products & Services
NewsNewsletterVideosOptions
SG60AdvertisingT&CsSitemap
About Us
Our CompanyContact UsEditorial TeamJoin Us
Advertise with usFAQsPrivacy PolicyMalaysiaEvents
© 2026 The Edge Publishing Pte Ltd. All rights reserved.